Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance

Cancer Cell(2025)10.1016/j.ccell.2025.03.031Source: DataRank Database

Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance is a research paper published in Cancer Cell (2025). On theSindex it has a DataRank of 0. It has been cited 94 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access94 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 45.39)OA: greenTopics (48)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (26)

Mingchuang Sun ORCID,Jun Cheng ORCID,Rui Ye ORCID,Zhengze Lu ORCID,Amber D. Horbath ORCID

Live enrichment

PubMed:40215978 OpenAlex:https://openalex.org/W4409329540

University of Texas MD Anderson Cancer Center

Grant: P30CA016672

Cancer Prevention and Research Institute of Texas

Grant: RP230072

Cancer Prevention and Research Institute of Texas

Grant: RP210028

NCI NIH HHS

Grant: U54 CA224081

NCI NIH HHS

Grant: U54 CA274220

NCI NIH HHS

Grant: R01 CA269646

NCI NIH HHS

Grant: R01 CA181196

NCI NIH HHS

Grant: R01 CA244144

NCI NIH HHS

Grant: R01 CA247992

FWCI

45.39

Citation Percentile

1.0%

Citation Trend

2025

2026

greenLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12151758/

publisherhttps://api.elsevier.com/content/article/PII:S1535610825001321?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610825001321?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ccell.2025.03.031

Fields of Study

MicroRNA in disease regulationCancer, Hypoxia, and MetabolismFerroptosis and cancer prognosisHumansRadiation ToleranceAnimalsCopperMiceCell Line, TumorEsophageal NeoplasmsMitochondriaCopper Transporter 1Xenograft Model Antitumor AssaysFerroptosisApoptosisMetallothioneinGene Expression Regulation, NeoplasticGlutathioneFemale

MeSH Terms

FerroptosisCopper Transporter 1AnimalsCopperEsophageal NeoplasmsFemaleGlutathioneHumansMetallothioneinMitochondriaRadiation ToleranceGene Expression Regulation, NeoplasticApoptosisXenograft Model Antitumor AssaysCell Line, TumorMice

Keywords

RadioresistanceCancer researchRadiation therapyBiologyInducerMedicineInternal medicineGeneticsGenecoppercuproptosismetallothioneinradiotherapy

Sustainable Development Goals

SDG 0: Good health and well-beingSDG 0: Zero hunger